Heramb Chadchankar

Company: Kynexis Therapeutics

Job title: Senior Director & Head of Translational Science

Seminars:

Opening Discussion: What Value Do EEG Biomarkers Offer as Translational Tools for Neuropsychiatric Drug Development? 9:10 am

What are the potential, or anticipated challenges, of leveraging EEG data to: Optimize dose selection: is EEG a relevant biomarker to leverage as a way of predicting and scaling therapeutic doses from animals into humans? Aid patient selection: how can EEG monitoring be optimized as an objective tool for patient stratification? Utilize as an outcome…Read more

day: EEG Focus Day

Demonstrating the Utility of qEEG Methods Including MisMatch Negativity in Schizophrenia Drug Development 2:30 pm

Utilizing qEEG methods in the development of a new therapeutic mechanism for schizophrenia Correlating mechanism of action with positive effects on EEG spectral analysis Future directions for incorporating qEEG and EEG measurements of mismatch negativity as clinical endpointsRead more

day: EEG Focus Day